Insurance specialty broker Ryan Specialty (NYSE: RYAN) will be announcing earnings results this Thursday afternoon. Here’s what you need to know.

Ryan Specialty beat analysts’ revenue expectations by 2.9% last quarter, reporting revenues of $754.6 million, up 24.8% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ organic revenue estimates and a solid beat of analysts’ revenue estimates.

Is Ryan Specialty a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Ryan Specialty’s revenue to grow 16.2% year on year to $771 million, slowing from the 24.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.49 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Ryan Specialty has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.3% on average.

Looking at Ryan Specialty’s peers in the insurance brokers segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Marsh & McLennan delivered year-on-year revenue growth of 8.7%, beating analysts’ expectations by 0.7%, and Arthur J. Gallagher reported revenues up 34.8%, in line with consensus estimates. Marsh & McLennan traded up 5.6% following the results while Arthur J. Gallagher was also up 1.4%.

Read our full analysis of Marsh & McLennan’s results here and Arthur J. Gallagher’s results here.

Debates around the economy’s health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the insurance brokers stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.6% on average over the last month. Ryan Specialty is down 11.6% during the same time and is heading into earnings with an average analyst price target of $64.31 (compared to the current share price of $44.14).

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.